您搜索了: gamitromicina (斯洛文尼亚语 - 英语)

1 ml vsebuje 150 mg gamitromicina.
1 ml contains 150 mg of gamithromycin

1 ml raztopine vsebuje 150 ml gamitromicina,
1 ml contains 150 mg of gamithromycin,

1 ml raztopine vsebuje 150 ml gamitromicina 1 mg monotioglicerola
1 ml contains 150 mg of gamithromycin 1 mg of monothioglycerol

varnost uporabe gamitromicina v obdobju brejosti in laktacije pri kravah ni bila raziskana.
the safety of gamithromycin during pregnancy and lactation has not been evaluated in cattle.

klinične študije so pokazale široko varnost uporabe gamitromicina za injiciranje pri ciljnih živalskih vrstah.
clinical studies have demonstrated the wide margin of safety for gamithromycin injection in the target species.

s študijami na laboratorijskih živalih niso bili ugotovljeni nobeni selektivni učinki gamitromicina na razvoj ali reprodukcijo.
based on laboratory animal data, gamithromycin has not produced any evidence of selective developmental or reproductive effects.

aktivna učinkovina:150 mg gamitromicina pomožne snovi: 1 mg monotioglicerola brezbarvna do bledo rumena raztopina.
active substance: 150 mg of gamithromycin excipients: 1 mg of monothioglycerol colourless to pale yellow solution.

akumulacija gamitromicina v pljučih je bila dokazana z visoko in dolgotrajno koncentracijo v pljučih in bronhialni tekočini, ki daleč presegajo vsebnost v krvni plazmi.
accumulation of gamithromycin in the lung has been demonstrated by high and sustained concentrations in the lung and bronchial fluid which far exceed those in blood plasma.

Širok spekter delovanja gamitromicina vključuje manheimia haemolytica, pasteurella multocida in histophilus somni, bakterijske povzročitelje, ki so najpogosteje povezani z brd.
the broad spectrum antimicrobial activity of gamithromycin includes mannheimia haemolytica, pasteurella multocida and histophilus somni, the bacterial pathogens most commonly associated with brd.

subkutano injiciranje enkratnega odmerka 6 mg gamitromicina/ kg telesne teže (kar ustreza 1ml/ 25 kg telesne teže).
single subcutaneous injection of 6 mg gamithromycin/ kg body weight (equivalent to 1 ml/ 25 kg body weight).

en odmerek s 6 mg gamitromicina/kg telesne teže (kar ustreza 1 ml/25 kg telesne teže) v področje vratu.
a single dose of 6 mg gamithromycin/kg body weight (equivalent to 1 ml/25 kg body weight) into the neck.

subkutano injiciranje enkratnega odmerka 6 mg gamitromicina/ kg telesne teže (kar ustreza 1ml/ 25 kg telesne teže) v področje vratu.
a single subcutaneous injection of 6 mg gamithromycin/ kg body weight (equivalent to 1 ml/ 25 kg body weight) in the neck.

Širok spekter delovanja gamitromicina vključuje manheimia haemolytica, pasteurella multocida,histophilus somni, actinobacillus pleuropneumoniae in haemophilus parasuis,bakterijske povzročitelje, ki so najpogosteje povezani z brd in srd.
the broad spectrum antimicrobial activity of gamithromycin includes mannheimia haemolytica, pasteurella multocida, histophilus somni, actinobacillus pleuropneumoniae and haemophilus parasuis, the bacterial pathogens most commonly associated with brd and srd.

višek koncentracije gamitromicina v pljučih je v manj kot 24 urah, z razmerjem pljuča – plazma >264, kar kaže na izjemno hitro absorbcijo gamitromicina v tarčno tkivo za brd.
gamithromycin levels in lung reached a maximum in less than 24 hr, with lung-to-plasma ratio of > 264 indicating that gamithromycin was absorbed rapidly into the target tissue for brd.

po intramuskularni aplikaciji gamitromicina pri prašičih v enkratnem odmerku 6 mg/kg telesne teže, je absorbcija učinkovine izjemno hitra, z viškom koncentracije v plazmi po 5 do 15 minutah in z dolgo biološko razpolovno dobo (približno 4 dni).
gamithromycin administered intramuscularly in pigs at single dose of 6 mg/kg body weight, resulted in rapid absorption with peak plasma concentrations observed after 5 to 15 min, with a long plasma half-life (about 4 days).